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Three different forms of recombinant human fibronectin polypcptider consisling of the amino-terminal 70 kDa region, the carboxyl-terminal 37 
kDa region, or both, were expressed in mouse L cells. Although either the amino-terminal or the carboxyl-terminal region alone was only poorly 
incorporated into theextracellular matrix, the fused form ofthc polypcptide was highlycapableofasscmbling i to the malrix. These results indicate 
that matrix asscmbiy of fibronectin requires both regions and can proceed in the absence ofmost of the type III repeats including theonecontaining 
the cell adhesive Arg-Gly-Asp sequence. 
Fibronectin: Extracellular matrix; Fibrillogenesis 
1. INTRODUCTION 
Fibronectin (FN) is a glycoprotein present in the ex- 
tracellular matrix and various body fluids [1,2]. FN 
synthesized and secreted by cells is incorporated into the 
extracellular matrix through a complex cell-mediated 
process [3]. Although the molecular mechanism of FN 
matrix assembly is as yet only poorly understood, the 
amino-terminal 70 kDa region and the central cell-bind- 
ing domain have been inplicated in the assembly process 
[4,5]. 
Recently, we have shown !.hat the carboxyl-terminal 
37 kDa fibrin-binding domail; of human FN retained 
the ability to dimerize when expressl?d in mouse L cells, 
but it was barely incorporated inro the extracellular 
matrix of the cells [6]. Given the suggested role of the 
amino-terminal 70 kDa region in the FN matrix as- 
sembly, we expressed in the present study the carboxyl- 
terminal 37 kDa domain in a fused form with the 
amino-terminal 70 kDa region (hereafter referred to as 
W’OF2’; see Fig. 1) and compared the ability of the 
recombinant protein to assemble into the extracellular 
matrix with that of other recombinant proteins consist- 
ing of either the amino-terminal 70 kDa (‘r70’) or the 
carboxyl-terminal 37 kDa (‘rF2’) region alone. 
2. MATERIALS AND METHODS 
2. I, DNA coitstructfun 
A cDNA clone pCF2h encoding the signal sequence and the amino- 
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terminal 70 kDa region of human FN was prepared by oligonu- 
cleotide-primed cDNA synthesis [7] using the poly(A)’ RNA is&led 
from SV40-transform~xl human fibroblast WI-38VAl3 as a template. 
A I.582 bp StsuI-Sun fragment encoding the amino-terminal 70 kDa 
region wss amplified from pCF26 using the polymerase chain reaction 
and inu:rted to the Sn~allNspV-clcavcd rF3 expression vector 
pAISF31 [6], together with either the 1,510 bp Xhol-NspV fragment 
of pHCF2D [6] encoding the carboxyl-terminal 37 kDa region of 
human FN or the 274 bp Sail-NspV fragment of pHCF2D encoding 
only the carboxyl-terminal I4 amino acid residues. 
Each expression vector described above was co-transfected to 
mouse L cells along with a selection marker pKO, by the calcium- 
phosphate precipitation method [8]. G4l8-resistant colonies wcrc 
screened for the expression of recombinant FN mRNAs by Northern 
blot analysis. Clones expressing the highest levels of the recombinant 
FN transcripts were used in the subsequent immunoprccipitation a d 
immunofluorescence experiments. 
2.3. i,rit,runopr~cipitation 
Mouse L cells were pulse-labeled witl-. [3SS]methioninc (American 
Radiolabeled Chemicals. MO) as described in [6]. Radiolabeled cells 
were solubilized with 20 mM Tris-HCI, pM 8.0, containing 1.5% 
sodium deoxycholate, 2 mM EDTA, 1 mM phenylmethylsulfonyl 
fluoride, and 2 mM N-cthylmaleimide with or without prior treatment 
with 2.5% TPCK (N-tosyl+phenylalanine chloromethyl ketone)- 
treated trypsin at 37°C for 5 min. followed by the addition of a large 
cxccss of soybean trypsin inhibitor. The cell lysates were immunopre- 
cipitated with monoclonal nti-human FN antibody FNP-I or FNS-I2 
immobilized on Sepharose CL4B (generous gifts tiom Mr. Masahiko 
Katayama, Takara Shuzo, Japan) and the precipitates were ana!@ 
by SDS-PAGE and subsequent fluoragraphy. 
2.4. Indirect itnttruno~t4arescettce staining 
The recon:binal.lt CN polypptidYs incorporated into the cxtracel- 
lular matrix were visualized by inkrect immunotluorescence using 
monoclonal anti-human FN antibodies TN9-I and FNB-I2 (‘ihkarrr 
Sh~o. Japan) or polyclonal anti-human FN antibody as described in
[61. 
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Fig. I. Schematic diagram of FN (A) and FN-derived recombinant polypeptides (B). FN consists of six functional domains with binding specificities 
toward heparin, fibrin, collagen, and cell surface integrins, These domains are made up with three types of internal homology repeats named types 
I, II, and III. It should be noted that rhe recombinant polypeptides lack most of the central type 111 repeats. 
3. RESULTS AND DISCUSSION 
The L cell transformants, L/70, L/201, and L/70F2, 
stably expressing r70, rF2, and r70F2, respectively, 
were pulse-labeled with [%]methionine and the recom- 
binant polypeptides were immunoprecipitated from 
both cell lysaces and the culture supernatants after a 6 
h chase. Almost all of the radiolabeled r70 was ecreted 
to the medium and barely retained on the cell surface 
or within cytoplasm (Fig. 2, lanes l-3). Similary, rF2 
was predominantly secreted into the medium as dif- 
ferentially glycosylated heterop.eneous polypeptides of 
60-90 kDa, leaving a small fraction associated with cells 
as 66 kDa, 54 kDa, and 5; kDa polypeptides (Fig. 2, 
lanes 4-6; see also [6]). Most of the cell-associated rF2 
polypeptides were degrated when the cells were created 
with trypsin, suggesting that they were exposed at the 
cell surface. 
In contrast, a significant amount of r70F2 was immu- 
nopresopitated from the cell lysate (Fig. 2, lines 7-9). 
irypsin treatment of LiiOF2 ceiis markedly reduced the 
amount of the cell-associated 7OF2, indicating that most 
of the 70F2 recovered in rhe cell lysate was present on 
the cell surface. SDS-PAGE of the unreduced r70F2 
sho*;ed that r70F2 was secreted into the medium as two 
major forms with molecular masses of 350 kDa and 200 
kDa (Fig. 2, lane 10). Since a significant amount of 
mouse FN was co-precipitated with r70F2, this was 
considered to be the heterodimer of r70F2 linked to 
mouse FN and the homodimer of r70F2. These results 
indicated that r70F2 expressed in mouse L cells retained 
the ability to demerize and was capable of assembling 
into the extracellular matrix. 
Assembly of these recombinant polypeptides into the 
extracellular matrix was further examined by immuno- 
fluorescence staining of the stably transformed L cells 
with monoclonal antibodies, FN9-1 and FN8-12, which 
specifically recognize the amino-terminal and the car- 
boxyl-terminal regions of human FN, respectively (Fig. 
3). Polyclonal anti-FN antibody was also used to visual- 
ize the whole FN matrix consisting of both endogenous 
mouse FS and recombinant human FN polypeptides. 
In spite o.F the presence of well-developed mouse FN 
matrix, r70 was not detectable on the surface of L/70 
cells (Fig. 3, A-C). Simiiariy, the matrix of L/F2 4s 
expressing the carboxyl-terminal 37 kDa region was 
only weakly stained with FN8-12 but not with FN9-1 
(Fig. 3, D-F). The matrix of L cells expressing r70F2 










Fig. 2. Immunoprecipitation of recombinant polypeptides expressed in mouse L cells. The cells expressing r70 (A), rF2 (B). or r70F2 (C) were 
metabolically labeled with [“Slmcthionine and chased with a large excess of cold methioninc for 6 h. The labeled recombinant polypeptides 
associated with cells before (Ian&5 1,4,7) or aher lrypsin treatment (lanes 2, 5,s) as well as those secreted into the medium (lanes 3,6,9, IO) were 
immunoprecipitated with manoclonal antibody specific to human FN. lmmunoprccipitatrxl polypeptides were analyzed by SDS-PAGE under 
reduced (lanes l-9) or unreduced (lane IO) conditions. r70F2 exists as a homodimer (HOD) as well as a heterodimer linked to mouse FN (HcD). 
Open and closed arrowheads and bracket indicate the position of the secreted recombinant polypcptides. Asterisks indicate rhc putative precursor 
forms of rF2. 
was, however, strongly pwitive for immunostaining 
with both FN9-1 and FN8.12 (Fig. 3, G-I), confirming 
that r70F2 was capable of assembling into the extracel- 
lular matrix. These results, taken together with the 
observations with immunoprecipitation f pulse-labeled 
recombinant polypeptides, indicated that both the 
amino-terminal 70 kDa and the carboxyl-terminal 37 
kDa regions are necessary for incorporation of FN into 
the extracellular matrix. 
Monoclonal antibodies directed to the cell-binding 
domain have been shown to !.nhibit incorporation of FN 
into matrix [5,9], suggesting that surface fibronectin re- 
ceptor, i.e as/31 integrin, is involved in FN matrix as- 
sembly. Our observation that r70F2 was capable of as- 
sembling into the matrix, however, indicates that inter- 
action of FN with 1~5~1 integrin is not prerequisite for 
FN matrix assembly, since r7CF2 is devoid of almost all 
of the FN type III repeats including the one containing 
the ceil adhesive XC3 sequcncc. 
FN matrix assembly is considered to be a process 
consisting of two consecutive vents, i.e. nucleation and 
elongation of FN fibrils. Since mouse L cells produce 
an elaborated FN matrix, the incorporation of r70F2 
into the extracellular matrix may not mquire nucleation 
of the 70F2 fibrils and proceed only through the elonga- 
tion event, i.e. addition of r70F2 to the presxisting 
mouse FN fibrils. The interaction of FN with a5Bl 
integrin may well be important in the nuceation of FN 
fibrils. 
After the completion of this work, Schwarzbauer [IO] 
reported that the carboxyl-terminal half of rat FN be- 
came capable of assembling into the extracellular 
matrix when expressed in mouse WI2 cells as a fusion 
polypeptide with the amino-terminal 70 kDa region. 
Our results are in good agreement wit.h this observation 
and further narrow-down the minimal carboxyl-ter- 
minal region required for FN matrix assembly to the 
fibrin-binding 37 kDa region. 
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Fig. 3. lmmunofluorescence staining of the FN matrix of stable transformants. Mouse L cells expressing r70 (A-C), rF2 (D-F), and r70F2 (G-I) 
were stained with monoclonal anti-human FN antibodies FN9.1 (A. D, G) and FN8.12 (B, E, H) as well as with polyclonal anti.FN antibody 
(C, F, I). Scale bar = IO pm. 
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